3
May

Dr. Leonard Gomella: “Blue light” cystoscopy for detection and treatment of non-muscle invasive bladder cancer

Dr. Leonard Gomella, MD In patients with non-muscle invasive bladder cancer, fluorescence cystoscopy can improve the detection and ablation of bladder tumors. In this paper we describe the technique and practical aspects of hexaminolevulinate (HAL) fluorescence cystoscopy, also known as “blue light cystoscopy”. Check out Dr. Gomella’s  Blue Light Video (Click Here)

27
Apr

Jefferson Harnessing “Big Data” to Broaden Cancer Research

With the help of internal and external collaborations, researchers in our Computational Medicine Center (CMC) at the Sidney Kimmel Medical College here at TJU are characterizing and analyzing the molecular drivers of several cancers, which may lead to more powerful diagnostics and personalized treatments that better target cancer’s root causes. The use of precision medicine …

26
Apr

Researchers Find Pathway that Could Make Abandoned Pancreatic Cancer Drug Effective Against the Disease

Our scientists have found that blocking one molecular pathway could make pancreatic cancer susceptible to formerly ineffective therapies. “While there’s more work to be done to confirm the results in pre-clinical models and then humans, we are encouraged by these preliminary results,” said Jonathan Brody, PhD, a researcher at our Sidney Kimmel Cancer Center and Director …

23
Apr

Dr. Gomella featured in Targeted Oncology

Experts Discuss Treatment Sequencing Strategies in CRPC As the treatment landscape for patients with metastatic castration-resistant prostate cancer (CRPC) continues to evolve, optimal strategies are becoming more apparent on how to best sequence the multitude of novel therapies that have been approved in the past decade. To gain insight into current best practices and strategies …

21
Apr

Dr. Dicker featured in Oncology Times: The Role of Genomics in Prostate Cancer Care

Fertile Genomic Ground Leads to Growth of Technology, Knowledge Laberta, Valerie As medical oncology harvests the advantages of this fertile genomic age, so do the associated therapies that benefit cancer patients. Radiation oncology has sprouted some new opportunities for improved patient care and outcomes, now ripening with the help of technology and research. Adam Dicker, …

15
Apr

Reimagining Patient Engagement: Jefferson-Designed Application Helps Patients Make More-Informed Shared Medical Decisions

Making decisions about healthcare options can seem overwhelming to patients and their families, and, in many cases, patients are asked to make decisions even though they have a limited understanding of their options. The Decision Counseling Program (DCP) is an online software application that enables patients to make well-informed healthcare decisions together with their treating …

11
Apr

Brittany Simone awarded AACR Travel Grant from Taconic

  Taconic Celebrates Researchers Awarded AACR Travel Grant The AACR Annual Meeting is the premier meeting for cancer research. The 2016 meeting will be held April 16-20 in New Orleans, Louisiana, USA. The program includes sessions on precision checkpoint immunotherapy, CRISPR in drug discovery, CAR T cells, immunotherapy combination treatments, and much more. Taconic has provided four …

7
Apr

Radiation Oncology Podcast: Residency Program

Check out the latest Radiation Oncology podcast version 4 focusing on the Radiation Oncology residency program featuring : http://jdc.jefferson.edu/radoncjefferson/4/       Adam Dicker, MD, PhD Michael Hardin, MS, MPR2 Amy S. Harrison, MS Virginia Lockamy, PhD                     Emily Kremmel, MMP, MPR2 James Keller, PhD   …

4
Apr

Dr. Mitchell named to the Blue Ribbon Panel

Vice-President Biden’s National Cancer Moonshot Initiative Today, the National Cancer Institute (NCI), part of the National Institutes of Health, announced a Blue Ribbon Panel of scientific experts, cancer leaders, and patient advocates that will inform the scientific direction and goals at NCI of Vice President Joe Biden’s National Cancer Moonshot Initiative. The panel will serve …

1
Apr

Dr. Adam Dicker featured in OncologyNurseAdvisor

Radiotherapy/Histone Deacetylase Inhibitor Combination Safe, Effective in High-grade Gliomas Adding panobinostat to radiotherapy appears safe, tolerable, and has preliminary efficacy for treating recurrent high-grade gliomas, according to a phase 1 clinical trial published in the Journal of Neuro-Oncology. The trial combined fractionated stereotactic re-irradiation therapy (FSRT) with panobinostat.1 “We saw synergy between radiotherapy and the …

31
Mar

Conserved gene can act to inhibit lung cancer development, study finds featuring SKCC Researcher Dr. Bo Lu

Scientists believe that “conserved” genes — those found in life forms that range from bacteria to plants, insects and humans — perform vital biological functions across species. And limited research on one of those genes, Nitrilase 1 (Nit1), suggested it acts to inhibit cancer development. But researchers at Sidney Kimmel Cancer Center have found Nit1 …

30
Mar

Dr. Ronald Myers featured on PCORI Blog

Family Physicians Must Demystify Colorectal Cancer Screening During the nearly two decades I worked as a health correspondent for our local NBC affiliate, my cameraman was a kind, funny man who seemed to know everyone in town. Phil not only was my colleague but also my friend. PCORI’s Colorectal Cancer Focus PCORI has funded 51 …

22
Mar

Amy Callahan, DNP featured in Oncology Nursing Forum

Factors Influencing Nurses’ Use of Hazardous Drug Safe-Handling Precautions Hazardous drugs (HDs) are defined by the National Institute for Occupational Safety and Health ([NIOSH], 2004) using one or more of the following criteria: carcinogenicity, teratogenicity, reproductive toxicity, genotoxicity, organ toxicity at low doses, and drugs that mimic existing HDs in structure or toxicity. Most of …

17
Mar

Celeste Vaughn-Briggs appointed to Breast Cancer Disparities Committee

Breast Cancer Disparities Conference Susan G. Komen April 5, 2016 Philadelphia, PA Celeste Vaughan-Briggs, LCSW, Oncology Social Worker and Manager of the Free Breast and Cervical Cancer Screening Program at Thomas Jefferson University’s (Jefferson’s) Sidney Kimmel Cancer Center was invited to participate in the Roundtable discussion at the upcoming Susan G. Komen’s Breast Cancer Disparities …

Page 1 of 21